SBC Medical Group Holdings Incorporated SBC R2K
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Healthy ROCE of 25.7%.
- Excellent profit margin of 24.1%.
- Profit CAGR of 100.6% over 5 years.
- Generates positive free cash flow.
CONS
- Revenue declined at -0.1% CAGR over 5 years.
- Trading 43.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SBC SBC Medical Group Holdings Incorporated R2K | 3.21 | 8.03 | $330.14M | - | 25.75% | 16.46% | -0.11% | 100.61% |
| 2 | CAT Caterpillar Inc. SPX | 875.87 | 43.66 | $403.42B | 0.69% | 19.42% | 51.33% | 4.38% | 9.83% |
| 3 | GE GE Aerospace SPX | 323.76 | 40.17 | $338.27B | 0.58% | 11.89% | 45.43% | 16.32% | 195.89% |
| 4 | GEV GE Vernova Inc. SPXAI | 968.32 | 28.33 | $260.21B | 0.21% | 6.30% | 75.71% | 8.68% | 92.84% |
| 5 | RTX RTX Corporation SPX | 179.66 | 33.64 | $241.95B | 1.54% | 9.41% | 11.57% | 9.72% | 9.01% |
| 6 | UNP Union Pacific Corporation SPX | 262.64 | 21.60 | $155.93B | 2.10% | 16.19% | 40.69% | -0.49% | 0.66% |
| 7 | ETN Eaton Corporation plc SPXAI | 400.60 | 39.20 | $155.55B | 1.10% | 16.23% | 20.84% | 9.77% | 18.41% |
| 8 | HON Honeywell International Inc. NDXSPX | 237.86 | 38.00 | $150.72B | 2.00% | 13.57% | 24.26% | 1.82% | -1.62% |
| 9 | DE Deere & Company SPX | 542.18 | 30.67 | $146.45B | 1.20% | 12.82% | 18.35% | -4.50% | -11.00% |
Quarterly Results
Figures in USD.
| Metric | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 47.28M | 54.81M | 53.10M | - | - | 47.33M | 43.36M | 43.35M | 39.57M | 43.06M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | 9.60M | 13.35M | 12.74M | 10.64M | 12.71M |
| Gross Profit | - | - | - | - | 33.50M | 39.52M | 39.42M | - | - | 37.73M | 30.01M | 30.61M | 28.93M | 30.35M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | 13.53M | 15.46M | 14.73M | 16.08M | 12.63M |
| Operating Income | -1.28K | -303.62K | -388.45K | -473.37K | 20.02M | 24.46M | 27.29M | - | - | 24.20M | 14.55M | 15.88M | 12.85M | 17.72M |
| EBITDA | - | - | - | - | - | - | - | - | - | 32.09M | 14.23M | 19.30M | 19.30M | 19.64M |
| Interest Expense | - | - | - | - | - | - | - | - | - | 6.21K | 49.65K | 48.63K | 56.09K | 114.81K |
| Pretax Income | - | - | - | - | - | - | - | - | - | 31.45M | 13.54M | 18.51M | 18.57M | 18.86M |
| Tax Provision | - | - | - | - | - | - | - | - | - | 9.96M | 11.10M | 5.67M | 4.29M | 7.53M |
| Net Income | -1.28K | -11.42K | 613.33K | 196.79K | 8.36M | 18.76M | 18.48M | - | - | 21.50M | 2.46M | 12.82M | 14.20M | 11.31M |
| Diluted EPS | - | - | - | - | 0.09 | 0.20 | 0.20 | - | - | 0.21 | 0.02 | 0.12 | 0.14 | 0.11 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 174.16M | 193.54M | 205.42M | 173.61M |
| Cost of Revenue | 59.33M | 56.24M | 49.37M | 46.32M |
| Gross Profit | 114.83M | 137.30M | 156.05M | 127.28M |
| Operating Expenses | 93.48M | 66.23M | 70.69M | 59.80M |
| Operating Income | 21.35M | 71.07M | 85.36M | 67.49M |
| EBITDA | 29.64M | 85.87M | 77.28M | 84.91M |
| Interest Expense | 31.44K | 45.29K | 28.30K | 160.58K |
| Pretax Income | 23.68M | 73.58M | 73.46M | 82.07M |
| Tax Provision | 18.12M | 35.02M | 26.77M | 31.02M |
| Net Income | 6.32M | 39.37M | 46.61M | 50.99M |
| Diluted EPS | 0.06 | 0.39 | 0.48 | 0.50 |
Compounded Sales Growth
| 5 Years: | -0.11% |
| 1 Year: | -9.00% |
Compounded Profit Growth
| 5 Years: | 100.61% |
| 1 Year: | -47.10% |
Stock Price Performance
| 1 Year: | -37.43% |
| 6 Months: | -7.49% |
| 3 Months: | -16.84% |
| 1 Month: | -2.73% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 225.48M | 258.81M | 266.08M | 380.45M |
| Current Assets | 112.95M | 165.91M | 184.45M | 231.22M |
| Cash & Equivalents | 51.74M | 103.02M | 125.04M | 163.77M |
| Inventory | 1.35M | 3.09M | 1.49M | 2.79M |
| Receivables | 13.09M | 35.11M | 30.26M | 29.90M |
| Total Liabilities | 117.63M | 115.00M | 71.06M | 117.14M |
| Current Liabilities | 101.25M | 92.45M | 61.19M | 61.12M |
| Long Term Debt | 5.53M | 13.01M | 6.51M | 33.73M |
| Total Debt | 16.13M | 22.87M | 12.21M | 51.64M |
| Total Equity | 105.25M | 142.16M | 195.11M | 248.28M |
| Shares Outstanding | 100.74M | 100.74M | 103.02M | 103.88M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -47.37K | 50.67M | 20.58M | 24.67M |
| Investing Cash Flow | -32.65M | 1.79M | -10.10M | -20.97M |
| Financing Cash Flow | -7.98M | 6.14M | 22.97M | 38.29M |
| Capital Expenditure | -24.95M | -11.21M | -3.41M | -2.70M |
| Free Cash Flow | -24.99M | 39.46M | 17.17M | 21.96M |
| Net Change in Cash | -40.68M | 58.60M | 33.45M | 41.99M |
| Share Buybacks | - | - | 0 | 5.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 65.9% | 70.9% | 76.0% | 73.3% |
| Operating Margin % | 12.3% | 36.7% | 41.6% | 38.9% |
| Net Margin % | 3.6% | 20.3% | 22.7% | 29.4% |
| ROE % | 6.0% | 27.7% | 23.9% | 20.5% |
| ROCE % | 17.2% | 42.7% | 41.7% | 21.1% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 0.41% | 419.64K | $1.35M |
| 2 | Geode Capital Management, LLC | 0.29% | 295.78K | $949.45K |
| 3 | Vanguard Capital Management LLC | 0.13% | 136.24K | $437.33K |
| 4 | Northern Trust Corporation | 0.09% | 91.14K | $292.56K |
| 5 | Segall Bryant & Hamill, LLC | 0.08% | 81.31K | $261.00K |
| 6 | Vanguard Portfolio Management LLC | 0.06% | 63.55K | $203.99K |
| 7 | Vanguard Fiduciary Trust Co | 0.06% | 62.47K | $200.54K |
| 8 | SBI Securities Co., Ltd. | 0.04% | 45.08K | $144.71K |
| 9 | State Street Corporation | 0.03% | 30.84K | $98.99K |
| 10 | Goldman Sachs Group Inc | 0.02% | 25.09K | $80.53K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SBC